INTERNATIONAL PATENT: CHINESE INSTITUTES FOR MEDICAL RESEARCH, BEIJING, 首都医学科学创新中心 FILES APPLICATION FOR "KLHL24 UBIQUITIN LIGASE INHIBITOR AND USE THEREOF"

GENEVA, Feb. 16 -- CHINESE INSTITUTES FOR MEDICAL RESEARCH, BEIJING (No.10 YouAnMenWai TouXiTiaoFengtai District, Beijing 100069), 首都医学科学创新中心 (中国北京市丰台区右安门外西头条10号) filed a patent application (PCT/CN2025/113006) for "KLHL24 UBIQUITIN LIGASE INHIBITOR AND USE THEREOF" on Aug 06, 2025. With publication no. WO/2026/032336, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization...